Google Scholar citation report
Citations : 13553

Journal of Basic and Clinical Pharmacy received 13553 citations as per google scholar report

Indexed In

Chris Edward*
 
Department of Biotechnology, Princeton University, Princeton, New Jersey, USA
 
*Correspondence: Chris Edward, Department of Biotechnology, Princeton University, Princeton, New Jersey, USA, Email: chrised@zylker.com

Received: 16-Nov-2023, Manuscript No. Jbclinphar-23-124692; Editor assigned: 20-Nov-2023, Pre QC No. Jbclinphar-23-124692 (PQ); Reviewed: 04-Dec-2023 QC No. Jbclinphar-23-124692; Revised: 11-Dec-2023, Manuscript No. Jbclinphar-23-124692 (R); Published: 18-Dec-2023

Citation: Edward C. Nephrology Pharmacy for Improved Clinical Results. J Basic Clin Pharma.2023,14(6):324.

This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact reprints@jbclinpharm.org

Description

The research and treatment of kidney-related disorders is the focus of the discipline of nephrology, which is an important frontier in modern healthcare. Chronic Kidney Disease (CKD) and its consequences are a significant worldwide healthcare burden that need specialist care and a multidisciplinary approach.

The growing burden of kidney diseases

Chronic kidney disease affects millions of people worldwide, with its prevalence on the rise. According to the World Health Organization (WHO), an estimated 10% of the global population is affected by CKD, and the numbers continue to escalate. CKD not only places a significant burden on healthcare systems but also significantly impairs the quality of life for individuals grappling with this silent epidemic.

Nephrology pharmacy

Nephrology pharmacy develops as a specialist area that manages the particular issues associated with kidney disorders and its complicated medication. Nephrology pharmacists have an understanding of the renal system, helping them to handle the challenges of drug management in patients with impaired kidney function.

Medication management in the context of renal function

One of the most important roles of nephrology pharmacists is to optimize prescription regimens for people with kidney problems. Kidneys has an important role in drug excretion and impaired renal function may significantly impact pharmaceutical pharmacokinetics. Nephrology pharmacists methodically examine each patient’s renal function, partnering with healthcare teams to optimize prescription quantities, identify suitable treatments.

Individualized care

The dedication to customized patient care is the distinguishing feature of nephrology pharmacy. Nephrology pharmacists collaborate closely with nephrologists, nurses and other healthcare professionals to create pharmaceutical methods that are customized to each patient’s specific requirements. Furthermore, nephrology pharmacists frequently participate in patient education by encouraging patients to take an active role in their healthcare journey. Understanding the significance of taking medications, dietary modifications is critical for kidney disease patients.

The complexity of polypharmacy in kidney diseases

Polypharmacy, or the use of many drugs at the same time, is a typical difficulty in the treatment of renal illnesses. Multiple illnesses such as hypertension, diabetes and cardiovascular disease are common in CKD patients by necessitating the administration of many drugs. Nephrology pharmacists manage this complication by completing thorough medication evaluations by detecting potential drug interactions and working with healthcare teams to simplify prescription systems. In addition to polypharmacy management, nephrology pharmacists actively participate in drug reconciliation during care transitions. Whether a patient is being discharged from the hospital or transferring from one healthcare environment to another, the pharmacist maintains medication management continuity, reducing the risk of medication mistakes and some effects.

Innovations in renal replacement therapy

Renal Replacement Therapy (RRT), which includes haemodialysis and Peritoneal Dialysis (PD), is an essential component of ESRD care. Nephrology pharmacists has an important role in improving drug treatment for RRT patients. This involves changing drug dosages based on dialysis method, taking into account pharmacokinetic modifications associated with dialysis and avoiding drug-related problems. Furthermore, nephrology pharmacists are actively involved in the administration of drugs used during dialysis operations. In the context of renal replacement treatment, anticoagulants, erythropoiesis- stimulating medicines, and phosphate binding agents are among the drugs that require careful monitoring and modification.

Challenges in nephrology pharmacy

Despite the significant contributions of nephrology pharmacists, this specialized area has a number of problems. When compared to the increasing frequency of kidney disorders, the shortage of nephrology pharmacists is a significant problem. The technical details and regular updates of renal pharmacology also provide difficulties. To deliver evidence-based and patient-centered care, nephrology pharmacists must remain relevant on the latest research, treatment recommendations, and novel medicines. Professional growth and partnership with academic institutions will be important in solving the problem.